title: Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage.
authors.affiliation: Department of Gastroenterology, La Paz University Hospital. Madrid, Spain. luisaadan@gmail.com
authors.forename: L
authors.initials: L
authors.lastname: Adán-Merino
authors.forename: A
authors.initials: A
authors.lastname: Olveira-Martín
authors.forename: C
authors.initials: C
authors.lastname: Prados
authors.forename: F
authors.initials: F
authors.lastname: Gea-Rodríguez
authors.forename: P
authors.initials: P
authors.lastname: Castillo-Grau
authors.forename: E
authors.initials: E
authors.lastname: Martín-Arranz
authors.forename: J C
authors.initials: JC
authors.lastname: Sáenz
authors.forename: J M
authors.initials: JM
authors.lastname: Segura-Cabral
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications* / Q000601:surgery*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D016040:Lung Transplantation / Q000502:physiology*; D008297:Male; D011168:Portal System / Q000473:pathology; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons